The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use

OBJECTIVE: To determine the impact of maternal and fetal single nucleotide polymorphisms (SNPs) in key betamethasone (BMZ) pathways on neonatal outcomes. STUDY DESIGN: DNA was obtained from women given BMZ and their infants. Samples were genotyped for 73 exploratory drug metabolism and glucocorticoi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Haas, David M., Lehmann, Amalia S., Skaar, Todd, Philips, Santosh, McCormick, Catherine L., Beagle, Kyle, Hebbring, Scott J., Dantzer, Jessica, Li, Lang, Jung, Jeesun
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3340461/
https://ncbi.nlm.nih.gov/pubmed/22445700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2012.02.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars